Compare BDSX & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | SACH |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.0M | 52.0M |
| IPO Year | 2020 | 2017 |
| Metric | BDSX | SACH |
|---|---|---|
| Price | $7.95 | $1.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.50 | $2.00 |
| AVG Volume (30 Days) | 63.1K | ★ 232.7K |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 16.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,173,000.00 | $3,906,000.00 |
| Revenue This Year | $20.75 | N/A |
| Revenue Next Year | $25.05 | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.29 | N/A |
| 52 Week Low | $3.44 | $0.80 |
| 52 Week High | $32.20 | $1.40 |
| Indicator | BDSX | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 60.16 |
| Support Level | $7.77 | $1.00 |
| Resistance Level | $8.38 | $1.16 |
| Average True Range (ATR) | 0.57 | 0.05 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 60.38 | 69.57 |
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.